These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7897163)

  • 1. High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome.
    Kimata H
    J Allergy Clin Immunol; 1995 Mar; 95(3):771-4. PubMed ID: 7897163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of intravenous gamma-globulin for Kawasaki disease: effects on cardiac sequelae.
    Yanagawa H; Nakamura Y; Sakata K; Yashiro M
    Pediatr Cardiol; 1997; 18(1):19-23. PubMed ID: 8960487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
    Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
    Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
    van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
    Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome.
    Hsu CH; Chen MR; Hwang FY; Kao HA; Hung HY; Hsu CH
    Pediatr Infect Dis J; 1993 Jun; 12(6):509-12. PubMed ID: 8345983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome.
    Becker KL; Rösler B; Wang X; Lachmandas E; Kamsteeg M; Jacobs CW; Joosten LA; Netea MG; van de Veerdonk FL
    Clin Exp Allergy; 2016 Dec; 46(12):1564-1574. PubMed ID: 27474157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
    Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum immunoglobulin E (IgE): when to suspect hyper-IgE syndrome-A 10-year pediatric tertiary care center experience.
    Joshi AY; Iyer VN; Boyce TG; Hagan JB; Park MA; Abraham RS
    Allergy Asthma Proc; 2009; 30(1):23-7. PubMed ID: 19331717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
    Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
    Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Kawasaki disease on migration of human umbilical vein endothelial cells.
    Sakata K; Kita M; Imanishi J; Onouchi Z; Liu Y; Mitsui Y
    Pediatr Res; 1995 Oct; 38(4):501-5. PubMed ID: 8559600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose gammaglobulin treatment for atopic dermatitis.
    Kimata H
    Arch Dis Child; 1994 Apr; 70(4):335-6. PubMed ID: 8185369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.
    Furukawa S; Matsubara T; Umezawa Y; Motohashi T; Ino T; Yabuta K
    Eur J Pediatr; 1994 Sep; 153(9):663-7. PubMed ID: 7957426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
    Muta H; Ishii M; Egami K; Furui J; Sugahara Y; Akagi T; Nakamura Y; Yanagawa H; Matsuishi T
    J Pediatr; 2004 Apr; 144(4):496-9. PubMed ID: 15069399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
    Sato N; Sugimura T; Akagi T; Yamakawa R; Hashino K; Eto G; Iemura M; Ishii M; Kato H
    Pediatr Int; 1999 Feb; 41(1):1-7. PubMed ID: 10200128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin.
    Furukawa S; Matsubara T; Jujoh K; Sasai K; Nakachi S; Sugawara T; Yabuta K; Kato H
    Eur J Pediatr; 1990 Nov; 150(1):43-7. PubMed ID: 1706665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.
    Terai M; Shulman ST
    J Pediatr; 1997 Dec; 131(6):888-93. PubMed ID: 9427895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of vascular leakage in acute Kawasaki disease.
    Terai M; Honda T; Yasukawa K; Higashi K; Hamada H; Kohno Y
    Circulation; 2003 Jul; 108(3):325-30. PubMed ID: 12835221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary risks after high-dose gamma-globulin in children with Kawasaki disease.
    Morikawa Y; Ohashi Y; Harada K; Asai T; Okawa S; Nagashima M; Katoh T; Baba K; Furusho K; Okuni M; Osano M
    Pediatr Int; 2000 Oct; 42(5):464-9. PubMed ID: 11059532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of omalizumab in a patient with hyper-IgE syndrome and review dermatologic manifestations.
    Chularojanamontri L; Wimoolchart S; Tuchinda P; Kulthanan K; Kiewjoy N
    Asian Pac J Allergy Immunol; 2009 Dec; 27(4):233-6. PubMed ID: 20232578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.